Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium.
Saved in:
| Title: | Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium. |
|---|---|
| Authors: | Geoerger B; Department of Paediatrics, Institut Gustave Roussy, 39 Rue Camille Desmoulins, 94805 Villejuif, France. geoerger@igr.fr, Morland B, Ndiaye A, Doz F, Kalifa G, Geoffray A, Pichon F, Frappaz D, Chatelut E, Opolon P, Hain S, Boderet F, Bosq J, Emile JF, Le Deley MC, Capdeville R, Vassal G |
| Corporate Authors: | Innovative Therapies for Children with Cancer European Consortium |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2009 Sep; Vol. 45 (13), pp. 2342-51. Date of Electronic Publication: 2009 Apr 09. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
